1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. US Helicobacter Pylori Non-Invasive Testing Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. US Helicobacter Pylori Non-Invasive Testing Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. US Helicobacter Pylori Non-Invasive Testing Market Country Analysis
6.1 US Helicobacter Pylori Non-Invasive Testing Market Overview
6.2 US Helicobacter Pylori Non-Invasive Testing Market Revenue 2020-2028 (US$ Million)
6.3 US Helicobacter Pylori Non-Invasive Testing Market Forecast Analysis
7. US Helicobacter Pylori Non-Invasive Testing Market Analysis – by Test Type
7.1 Urea Breath
- 7.1.1 Overview
- 7.1.2 Urea Breath: US Helicobacter Pylori Non-Invasive Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Test Method
- 7.2.1 Overview
- 7.2.2 Test Method: US Helicobacter Pylori Non-Invasive Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Serology
- 7.3.1 Overview
- 7.3.2 Serology: US Helicobacter Pylori Non-Invasive Testing Market – Revenue and Forecast to 2031 (US$ Million)
8. US Helicobacter Pylori Non-Invasive Testing Market Analysis – by Test Method
8.1 Laboratories Based and Point of Care
- 8.1.1 Overview
- 8.1.2 Laboratories Based and Point of Care: US Helicobacter Pylori Non-Invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
9. US Helicobacter Pylori Non-Invasive Testing Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Laboratories Based and Point of Care: US Helicobacter Pylori Non-Invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Reference Laboratories
- 9.2.1 Overview
- 9.2.2 Laboratories Based and Point of Care: US Helicobacter Pylori Non-Invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10. US Helicobacter Pylori Non-Invasive Testing Market – United States Analysis
10.1 United States
- 10.1.1 United States: US Helicobacter Pylori Non-Invasive Testing Market – Revenue
and Forecast to 2028 (US$ Million)
- 10.1.1.1 United States:
US Helicobacter Pylori Non-Invasive Testing Market Breakdown, by Test Type
- 10.1.1.2 United States:
US Helicobacter Pylori Non-Invasive Testing Market Breakdown, by Test Method
- 10.1.1.3 United States:
US Helicobacter Pylori Non-Invasive Testing Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. US Helicobacter Pylori Non-Invasive Testing Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Bioneer Corp
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Meridian Bioscience Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Abbott Laboratories
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Thermo Fisher Scientific Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Bio-Rad Laboratories Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Coris Bioconcept SPRL
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 DiaSorin SpA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Sekisui Diagnostics LLC
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 CerTest Biotec SL
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 QuidelOrtho Corporation
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For US Helicobacter Pylori Non-Invasive Testing Market
